Cargando…
Viral Replication Rate Regulates Clinical Outcome and CD8 T Cell Responses during Highly Pathogenic H5N1 Influenza Virus Infection in Mice
Since the first recorded infection of humans with H5N1 viruses of avian origin in 1997, sporadic human infections continue to occur with a staggering mortality rate of >60%. Although sustained human-to-human transmission has not occurred yet, there is a growing concern that these H5N1 viruses mig...
Autores principales: | Hatta, Yasuko, Hershberger, Karen, Shinya, Kyoko, Proll, Sean C., Dubielzig, Richard R., Hatta, Masato, Katze, Michael G., Kawaoka, Yoshihiro, Suresh, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951384/ https://www.ncbi.nlm.nih.gov/pubmed/20949022 http://dx.doi.org/10.1371/journal.ppat.1001139 |
Ejemplares similares
-
Growth of H5N1 Influenza A Viruses in the Upper Respiratory Tracts of Mice
por: Hatta, Masato, et al.
Publicado: (2007) -
A cell-based screening system for influenza A viral RNA transcription/replication inhibitors
por: Ozawa, Makoto, et al.
Publicado: (2013) -
Quadrivalent Formulation of Intranasal Influenza Vaccine M2SR (M2-Deficient Single Replication) Protects against Drifted Influenza A and B Virus Challenge
por: Hill-Batorski, Lindsay, et al.
Publicado: (2023) -
Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus
por: Hatta, Masato, et al.
Publicado: (2018) -
Longevity and Mechanism of Heterosubtypic Protection Induced by M2SR (M2-Deficient Single-Replication) Live Influenza Virus Vaccine in Mice
por: Sarawar, Sally, et al.
Publicado: (2022)